(1) The monitoring system shall be carried out, among others through

(a) periodic inspections of health facilities and other offices;

(b) collection of data from health care services rendered by health care facilities;

(c) periodic review of collected data to determine the quality, cost and effectiveness of service and adherence to accepted and known standards of health care practice;

(d)  peer review; and

(e)  a mandatory reporting mechanism approved by the Council.

(2) For the purposes of monitoring the performance of health care facilities, every accredited facility shall submit a quarterly report to the Council which shall include the following data for the quarter:

(a) patients attended to, classifying them into our patients and admitted (in-patients) patients as is applicable;

(b) bed occupancy;

(c) average length of admission of patients;

(d) mortality rate;

(e) five most common causes of admission;

(f)  ten most common causes of Out-Patients Department (OPD) attendance 

(g) types and the number of minor and major operations performed; and

(h) non-paying members of insurance schemes that were attended to. 

(3) For the purposes of monitoring the performance of pharmaceutical service providers, every accredited pharmaceutical service facility shall submit a quarterly report to the Council, which shall include the following:

(a) number of patients on the scheme attending the facility;

(b) number of patients attending the facility outside the scheme;

(c) number of prescriptions served

(i) fully,

(ii) partially,

(iii) unable to serve;

(d) interventions made and total cost saved for the scheme from non-dispensing of irrational or invalid prescriptions,

(e) top most five drugs dispensed; and

(f) number and type of extemporaneous preparations made.